(Q42992092)

English

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy

scientific article published in May 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Hiroaki Okamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Hajime Tokita

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hideo Fukui

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akihisa Tanaka

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hiroshi Kamitsukasa

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michiyasu Yagura

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hideharu Harada

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

752-758

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Analysis of hepatocellular carcinoma tumor growth detected in sustained responders to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Introduction to therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

The effect of light drinking on HCV liver disease: the jury is still out.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2005.03800.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2005.03800.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42992092&oldid=1975942278"